Am J Transplant, Volume 20, Suppl 3 Archives - Page 105 of 223 - ATC Abstracts

2020 American Transplant Congress
XBP1 Modulates Endoplasmic Reticulum and Mitochondria Crosstalk via Regulating NLRP3 Inflammasome in Renal Ischemia/Reperfusion Injury
H. Ni¹, Y. Liu¹, W. Deng¹, J. Zhang², J. Xu¹, W. Zeng¹, N. Gong², Y. Miao¹
¹Organ Transplant Department, Nanfang Hospital, Southern Medical University, Guangzhou, China, ²Institute of Organ Transplantation, Key Laboratory of the Ministry of Health and the Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
*Purpose: This study aims to investigate the molecular mechanism and function of X-box binding protein 1 (XBP1)- NLR family pyrin domain-containing 3 (NLRP3) signaling which…
2020 American Transplant Congress
Effects of Preoperative Intrathecal Morphine on Postoperative Pad in Living Donor Kidney Transplantation Recipients
K. Lee, M. Lim, J. Kwon, E. Jeong, J. Yang, M. Kim, J. Park
Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Postoperative PAD (pain, agitation, delirium), especially delirium in living donor kidney transplantation (LDKT) recipients is a risk factor for increased morbidity, duration of hospital…
2020 American Transplant Congress
Short Term Outcomes in Kidney Transplant Patients Receiving De Novo Belatacept with Anti-Thymocyte Globulin Induction
B. Carlson, P. Cabrera, T. Harrison, K. Tejani, A. Centeno
Pharmacy, Jackson Memorial Hospital, Miami, FL
*Purpose: Mainstay immunosuppressive therapy after kidney transplant is a calcineurin inhibitor (CNI) based regimen. Nephrotoxicity is a common adverse effect of CNIs which can lead…
2020 American Transplant Congress
Telehealth Medicine: A Novel Tool to Make Living Donation Simple and Financially Neutral
A. Yadav, M. Cantarin Martinez, P. Singh
Thomas Jefferson University, Philadelphia, PA
*Purpose: Live kidney donation can be an overwhelming process even for the highly motivated individuals. Live donors may have to spend up to $5000 for…
2020 American Transplant Congress
Outcomes after Declining Offers from Older Donor Kidneys for Kidney Transplant Candidates
J. D. Motter, L. Liyanage, K. R. Jackson, M. G. Bowring, T. Ishaque, Y. Yu, S. Yu, J. M. Garonzik-Wang, A. B. Massie, D. L. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: Older donor kidneys (ODKs) are often declined as they are associated with higher post-transplant mortality and graft loss, yet those who decline may wait…
2020 American Transplant Congress
Outcome Disparities of Primary Pediatric Kidney Transplant Recipients by Payor, Ethnicity and Gender in the United States
S. M. Riad¹, S. Jackson², A. Matas³, S. Chinnakotla³, P. Verghese⁴
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN, ⁴Pediatric, University of Minnesota, Minneapolis, MN
*Purpose: Racial disparity outcome in pediatric kidney recipients has been reported. We sought to assess other predictors of outcomes disparities.*Methods: Using the SRTR database, between…
2020 American Transplant Congress
Clinical Significance of Late Antibody-Mediated Rejection without Donor Specific Anti-hLA Antibodies
J. Lee¹, E. Kim¹, S. Yang¹, S. Kim¹, B. Lim², H. Choi³, B. Kim⁴, B. Kim⁴, M. Ju⁵, M. Kim¹, S. Kim¹, Y. Kim¹, K. Huh¹
¹Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, ²Department of Pathology, Yonsei University College of Medicine, Seoul, Korea, Republic of, ³Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of, ⁴Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, ⁵Department of Surgery, Gangnam Severance Hospital, Seoul, Korea, Republic of
*Purpose: Late onset antibody-mediated rejection (AMR) is a leading cause of kidney allograft failure. Its diagnosis has been based on a combination of morphologic, immunohistologic…
2020 American Transplant Congress
The Evolution of Renal Graft Failure Risk: The Power of the Proximal
T. Mayne¹, S. Mohan²
¹Angion Biomedica, San Francisco, CA, ²Columbia University Medical Center, New York, NY
*Purpose: Our goal was to examine the association of eGFR in the first year on long term outcomes following kidney transplant.*Methods: The sample included kidney…
2020 American Transplant Congress
New Everolimus Administration Targeting the Prevention of the Development of Antibody-Mediated Rejection Considering the Comparison of Growth and Survival in IgG and IgM Memory B Cells
Y. Matsuda¹, R. Imamura¹, H. Tezuka², S. Takahara¹
¹Osaka University Graduate School of Medicine, Suita, Japan, ²Fujita Health University, Toyoake, Japan
*Purpose: Some reports indicated that immunoglobulin (Ig) M antibodies corresponding to donor-specific antigen in addition to IgG antibodies are closely involved in the activation of…
2020 American Transplant Congress
Waitlist Mortality and Transplant Probability for Inactively Listed Liver Patients Depends on Donor Service Areas’ Median MELD at Transplant
R. Batra¹, S. Noreen², D. Stewart², D. Haakinson¹, G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Presently, the outcome of patients listed inactive on liver transplant waiting list (WL) are unknown; as inactive patients cannot receive deceased donor organ offers,…